Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -10.04x is 24% above its 5-year average of -13.29x, near the high end of its 5-year range (-34.88x–-2.47x).
12.37% below its 12-month average of -8.93x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -12.19x.
INTEREST COVERAGE RATIO
-10.04x
INTEREST COVERAGE RATIO AVG TTM
-8.93x
INTEREST COVERAGE RATIO AVG 3Y
-10.94x
INTEREST COVERAGE RATIO AVG 5Y
-13.29x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-12.37%
CURRENT VS 3Y AVG
+8.27%
CURRENT VS 5Y AVG
+24.47%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.54x
median of 430 covered companies
CURRENT VS SECTOR MEDIAN
-81.23%
vs the sector median at left
Celcuity Inc.
Market Cap
$3.56B
Interest Coverage Ratio
-10.04x
TTM Avg
-8.93x
3Y Avg
-10.94x
5Y Avg
-13.29x
Market Cap
$3.56B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.54B
Interest Coverage Ratio
-2.80x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.45B
Interest Coverage Ratio
N/A
TTM Avg
407.95x
3Y Avg
407.95x
5Y Avg
407.95x
Market Cap
$3.42B
Interest Coverage Ratio
-99.92x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.42B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.98B
Interest Coverage Ratio
1.01x
TTM Avg
0.71x
3Y Avg
0.54x
5Y Avg
40.25x
Market Cap
$3.13B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Celcuity Inc. (CELC) | $3.56B | -10.04x | -8.93x | -10.94x | -13.29x |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.56B | N/A | N/A | N/A | N/A |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.54B | -2.80x | N/A | N/A | N/A |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.45B | N/A | 407.95x | 407.95x | 407.95x |
| CareDx, Inc (CDNA)vs › | $3.43B | N/A | 0.59x | 0.59x | 0.59x |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.42B | -99.92x | N/A | N/A | N/A |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.42B | N/A | N/A | N/A | N/A |
| ICU Medical, Inc. (ICUI)vs › | $3.98B | 1.01x | 0.71x | 0.54x | 40.25x |
| Denali Therapeutics Inc. (DNLI)vs › | $3.13B | N/A | N/A | N/A | N/A |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.09B | N/A | N/A | N/A | N/A |
Interest Coverage
-10.0x
Debt/Equity
N/A
Current Ratio
8.93
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -12.19x |
| 2026-03-31 | -8.30x |
| 2025-12-31 | -7.98x |
| 2025-09-30 | -2.47x |
| 2025-06-30 | -13.74x |
| 2025-03-31 | -11.35x |
| 2024-12-31 | -11.12x |
| 2024-09-30 | -8.99x |
| 2024-06-30 | -10.74x |
| 2024-03-31 | -16.06x |
| 2023-12-31 | -14.12x |
| 2023-09-30 | -13.77x |
| 2023-06-30 | -11.45x |
| 2023-03-31 | -10.10x |
| 2022-12-31 | -17.17x |
| 2022-09-30 | -19.80x |
| 2022-06-30 | -21.08x |
| 2022-03-31 | -17.26x |
| 2021-12-31 | -14.43x |
| 2021-09-30 | -12.93x |
| 2021-06-30 | -34.88x |
| 2021-03-31 | -116323.75x |
| 2020-12-31 | -98128.31x |
| 2020-09-30 | -88574.11x |
| 2020-06-30 | -71417.45x |
| 2020-03-31 | -70024.64x |
| 2019-12-31 | -52715.67x |
| 2019-09-30 | -53623.46x |
| 2019-06-30 | -44919.98x |
| 2019-03-31 | -45918.67x |
| 2018-12-31 | -42417.52x |
| 2018-09-30 | -30397.55x |
| 2017-09-30 | -5.77x |
| 2017-06-30 | -8.60x |
